作者: Annette N Smith
DOI: 10.1016/S0195-5616(03)00002-0
关键词: CATS 、 Metastasis 、 Canine Hemangiosarcoma 、 Angiosarcoma 、 Chemotherapy 、 Medicine 、 Combined Modality Therapy 、 Pathology 、 Malignant hemangioendothelioma 、 Hemangiosarcoma
摘要: Hemangiosarcoma (HSA, including angiosarcoma and malignant hemangioendothelioma) is a highly tumor derived from the endothelial cell line characterized by early aggressive metastasis. HAS common type in dogs, but rare other species. Treatment options include surgery, chemotherapy, possibly radiation, survival times are invariably short (usually < 1 year), except for patients with superficial dermal HSAs. Further to treat this currently being investigated.